NCT07448883 Validity of the Turkish Translation of the Modified JOA
| NCT ID | NCT07448883 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Izmir Democracy University |
| Condition | Spondylosis, Cervical |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-05-10 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 70 participants in total. It began in 2026-05-10 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Degenerative cervical myelopathy (DCM) is the most common cause of non-traumatic spinal cord dysfunction in adults and may lead to progressive motor, sensory, and autonomic impairment. Accurate and standardized assessment of neurological function is essential for clinical decision-making, prognostic evaluation, and comparison of treatment outcomes. The Modified Japanese Orthopaedic Association (mJOA) score is one of the most widely used clinician-based outcome measures for evaluating neurological status in patients with DCM. Although the mJOA has been translated and validated in several languages, no validated Turkish version currently exists. This prospective, cross-sectional validation study aims to culturally adapt the mJOA score into Turkish and evaluate its validity, reliability, and clinical correlation in Turkish-speaking patients diagnosed with DCM. Adult patients (≥18 years) with clinically and radiologically confirmed DCM presenting to the outpatient clinics of Physical Medicine and Rehabilitation and Neurosurgery will be included. Previously obtained cervical magnetic resonance imaging will be reviewed retrospectively to determine myelomalacia levels, while clinical scales will be administered prospectively. Construct validity will be assessed by examining correlations between the Turkish mJOA scores and the Neck Disability Index, as well as the Nurick grading system. Inter-rater reliability will be evaluated using the Intraclass Correlation Coefficient (ICC \[2,1\]) between two independent evaluators, and test-retest reliability will be assessed in clinically stable patients after 7-14 days. Feasibility will be evaluated by recording the administration time and potential difficulties during application. This study is expected to provide a valid and reliable Turkish version of the mJOA score, facilitating standardized assessment of DCM in Turkish clinical practice and enabling comparability with international research.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years and older * Patients diagnosed with degenerative cervical myelopathy using clinical or magnetic resonance imaging * Able to provide written informed consent to participate in the study * Cognitive competence to understand Turkish forms and scales Exclusion Criteria: * Spinal cord injury due to trauma, tumor, infection, inflammatory diseases, etc., pathologies * Previous cervical surgery * Severe cognitive impairment or communication problems that would prevent participation in the study * Subjects who were informed about the study but refused to participate
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07448883 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spondylosis, Cervical. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07448883 currently recruiting?
Yes, NCT07448883 is actively recruiting participants. Contact the research team at kadir.93@gmail.com for enrollment information.
Where is the NCT07448883 trial being conducted?
This trial is being conducted at Buca, Turkey (Türkiye).
Who is sponsoring the NCT07448883 clinical trial?
NCT07448883 is sponsored by Izmir Democracy University. The trial plans to enroll 70 participants.